PharmaNutra SpA (MIL:PHN) FFO


MIL:PHN PharmaNutra SpA MIL:PHN
85 GF Score
Price €87.20
GF Value €71.41
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is PharmaNutra SpA FFO?

FFO (Funds from operations) only applies to REITs.

MIL:PHN
85GF Score
PharmaNutra SpA MIL:PHN
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is PharmaNutra SpA (MIL:PHN) Overvalued in 2026?

Based on GuruFocus' analysis, PharmaNutra SpA stock appears to be overvalued. The current stock price of €87.20 is trading 22.1% above its estimated GF Value™ of €71.41. GuruFocus considers PharmaNutra SpA to be Modestly Overvalued.

Key valuation signals for MIL:PHN:

  • FFO:
  • GF Value™: €71.41 vs. price of €87.20 (22.1% above fair value)
  • GF Score™: 85/100 with 6 warning signs

No single metric tells the full story. See the MIL:PHN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PharmaNutra SpA Business Description

Other Exchanges PHNm:UK761:Germany
Address Via Campodavela 1, Pisa, ITA, 56122
PharmaNutra SpA is a pharmaceutical company. The company is engaged in the research, design, development, and marketing of nutraceutical supplements and medical devices. The products of the company include SiderAL Folic, UltraMag, Cetilar, and others. The company operates in Europe, the Middle East, South America, the Far East, and other regions.
85GF Score

Get the complete analysis for MIL:PHN

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€87.20
Price
€71.41
GF Value